Cite
HARVARD Citation
Tomizawa, D. et al. (2018). Evaluation of high-dose cytarabine in induction therapy for children with de novo acute myeloid leukemia: a study protocol of the Japan Children's Cancer Group Multi-Center Seamless Phase II–III Randomized Trial (JPLSG AML-12). Japanese journal of clinical oncology. pp. 587-593. [Online].